Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users

Autor: Bo Zheng, James J. Kobie, Alexander F. Rosenberg, Brittany Carter, Michael S. Piepenbrink, William M Valenti, Atif Ali Khan, Catherine A. Bunce, Norman J. Haughey, Christopher F. Fucile, Sanjay B. Maggirwar, Memorie Samuel, Diane S. Morse, Juilee Thakar, Michael C. Keefer, Michelle Kiebala
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
B Cells
HIV Infections
Comorbidity
HIV Antibodies
Pathology and Laboratory Medicine
Systemic inflammation
Biochemistry
0302 clinical medicine
Immunodeficiency Viruses
Animal Cells
Substance Abuse
Intravenous

lcsh:Science
Immune Response
education.field_of_study
virus diseases
3. Good health
Blood
Medical Microbiology
Viral Pathogens
Physical Sciences
Vaccination and immunization
Cellular Types
Antibody
Immune Cells
CD40 Ligand
Immunology
Microbiology
03 medical and health sciences
Signs and Symptoms
Alkaloids
Recreational Drug Use
Humans
Antibody-Producing Cells
education
Microbial Pathogens
B cell
Pharmacology
Preventive medicine
Blood Cells
Tumor Necrosis Factor-alpha
lcsh:R
Organisms
Chemical Compounds
Biology and Life Sciences
Proteins
medicine.disease
Immunity
Humoral

Heroin
Cross-Sectional Studies
Public and occupational health
030104 developmental biology
Humoral immunity
lcsh:Q
030217 neurology & neurosurgery
RNA viruses
0301 basic medicine
Physiology
lcsh:Medicine
White Blood Cells
Cocaine
Immune Physiology
Medicine and Health Sciences
B-Lymphocytes
Vaccines
Immune System Proteins
Multidisciplinary
biology
Hematology
Hepatitis C
Body Fluids
Chemistry
medicine.anatomical_structure
Behavioral Pharmacology
Viruses
Female
Pathogens
Anatomy
medicine.symptom
Research Article
medicine.drug
Adult
Narcotics
Population
New York
Antibodies
Blood Plasma
Young Adult
Immune system
Diagnostic Medicine
Virology
Retroviruses
mental disorders
medicine
Inflammation
Hepatitis
Viral vaccines
business.industry
Interleukin-8
Lentivirus
HIV vaccines
HIV
Cell Biology
Transforming Growth Factor alpha
Immunoglobulin M
Immunoglobulin G
biology.protein
business
Zdroj: PLoS ONE, Vol 11, Iss 7, p e0158641 (2016)
PLoS ONE
ISSN: 1932-6203
Popis: Background Injection drug use is a growing major public health concern. Injection drug users (IDUs) have a higher incidence of co-morbidities including HIV, Hepatitis, and other infections. An effective humoral response is critical for optimal homeostasis and protection from infection; however, the impact of injection heroin use on humoral immunity is poorly understood. We hypothesized that IDUs have altered B cell and antibody profiles. Methods and Findings A comprehensive systems biology-based cross-sectional assessment of 130 peripheral blood B cell flow cytometry- and plasma- based features was performed on HIV-/Hepatitis C-, active heroin IDUs who participated in a syringe exchange program (n = 19) and healthy control subjects (n = 19). The IDU group had substantial polydrug use, with 89% reporting cocaine injection within the preceding month. IDUs exhibited a significant, 2-fold increase in total B cells compared to healthy subjects, which was associated with increased activated B cell subsets. Although plasma total IgG titers were similar between groups, IDUs had significantly higher IgG3 and IgG4, suggestive of chronic B cell activation. Total IgM was also increased in IDUs, as well as HIV Envelope-specific IgM, suggestive of increased HIV exposure. IDUs exhibited numerous features suggestive of systemic inflammation, including significantly increased plasma sCD40L, TNF-α, TGF-α, IL-8, and ceramide metabolites. Machine learning multivariate analysis distilled a set of 10 features that classified samples based on group with absolute accuracy. Conclusions These results demonstrate broad alterations in the steady-state humoral profile of IDUs that are associated with increased systemic inflammation. Such dysregulation may impact the ability of IDUs to generate optimal responses to vaccination and infection, or lead to increased risk for inflammation-related co-morbidities, and should be considered when developing immune-based interventions for this growing population.
Databáze: OpenAIRE